NF-kB signaling in the control of Hematopoiesis
NF-kB 信号传导在造血控制中的作用
基本信息
- 批准号:9238854
- 负责人:
- 金额:$ 38.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-15 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Erythroblastic LeukemiaAcute Myelocytic LeukemiaAdultAffectBindingBiochemicalBioinformaticsBiological AssayBiological ModelsCell Culture TechniquesCell CycleCell TransplantationCell physiologyCellsCellular biologyComputer SimulationCytokine ReceptorsDataDevelopmentDiseaseDysmyelopoietic SyndromesEmployee StrikesEngineeringEquilibriumGene Expression ProfilingGeneticGenetic TranscriptionHematologic NeoplasmsHematological DiseaseHematopoiesisHematopoieticHematopoietic stem cellsHemorrhageHumanHuman EngineeringImmuneImpairmentInflammatoryInterleukin-1 betaInvestigationKnock-in MouseLaboratoriesLinkMaintenanceMolecularMolecular TargetMusMyeloid LeukemiaMyeloproliferative diseaseNF-kappa BOnset of illnessPathologicPathologic ProcessesPathway interactionsPatientsPhenotypePhysiologicalProductionRegulationResearchRetrovirologyRoleSignal PathwaySignal TransductionSignal Transduction PathwaySiteStem cellsStressTNF geneTechniquesTestingTransplantationWorkXenograft Modelbasechromatin immunoprecipitationcytokineexhaustiongain of functionhigh riskhuman diseasehumanized mouseinnovationinsightleukemia treatmentmouse modelnovelprematurepreventpublic health relevanceresponseself-renewaltranscription factor
项目摘要
Project Summary:
NF-κB signaling pathway is one of the most extensively studied and understood
pathways, however, the physiological impact of augmented NF-κB signaling in
hematopoiesis has not been understood. Despite many recent studies documenting
constitutive activation of NF-κB in patients with hematological disorders, including AML
and MDS, it is remains unclear if constitutive NF-κB signaling is sufficient and/or
necessary for the onset of the disease. Recently, we have shown that lack of A20 (a
negative regulator of NF-κB) in hematopoietic stem cells (HSCs) causes loss of
quiescence and severe hematologic abnormalities, due to constitutive NF-κB activation.
In an attempt to decipher the role of NF-κB in HSCs, directly , we engineered mice to
constitutively activate NF-κB in HSCs. Our preliminary data indicate that HSC
quiescence and pool were completely lost, and that increased NF-κB signal alone was
sufficient to disturb the transcriptional regulatory circuits of HSCs. In the proposed
research, we would like to decode the potential molecular mechanisms through which
increased NF-κB signals affect HSC biology.
Our hypothesis is that deregulated canonical NF-κB signals impair hematopoietic
stem cell (HSC) quiescence and functions by altering signal transduction
pathways, `transcription factor networks' and expression of pro-inflammatory
cytokines. To test this hypothesis, we will use a combination of genetic, molecular cell
biology and biochemical approaches. In specific aim 1, we will decipher the intrinsic
mechanisms through which NF-κB affects HSC functions. In specific aim 2, we will
unravel the extrinsic role of NF-κB in the control of HSCs. In specific aim 3, we would
generate a novel humanized mouse model and decode the involvement of NF-κB
signals in human HSC biology.
We believe that the proposed research will provide key insights into the
pathologic processes involving deregulated NF-κB signals, and will aid the development
of newer and more successful therapies for human hematologic diseases that arise due
to constitutive NF-κB activation.
项目概要:
NF-κB 信号通路是研究和理解最广泛的信号通路之一
然而,增强 NF-κB 信号传导的生理影响
造血作用尚未被了解。尽管最近许多研究记录
血液系统疾病(包括 AML)患者中 NF-κB 的组成型激活
和 MDS,目前尚不清楚组成型 NF-κB 信号传导是否足够和/或
疾病发生所必需的。最近,我们发现缺乏 A20(a
造血干细胞 (HSC) 中的 NF-κB 负调节因子会导致
由于 NF-κB 的持续激活,导致静止期和严重的血液学异常。
为了直接破译 NF-κB 在 HSC 中的作用,我们对小鼠进行了改造
持续激活 HSC 中的 NF-κB。我们的初步数据表明 HSC
静止和池完全消失,仅增加 NF-κB 信号
足以干扰 HSC 的转录调节回路。在提议的
研究,我们想解码潜在的分子机制
NF-κB 信号增加会影响 HSC 生物学。
我们的假设是,规范 NF-κB 信号失调会损害造血功能
干细胞 (HSC) 静止并通过改变信号转导发挥作用
通路、“转录因子网络”和促炎因子的表达
细胞因子。为了检验这个假设,我们将结合遗传、分子细胞
生物学和生化方法。在具体目标1中,我们将破译内在的
NF-κB 影响 HSC 功能的机制。在具体目标2中,我们将
揭示 NF-κB 在 HSC 控制中的外在作用。在具体目标 3 中,我们将
生成新型人源化小鼠模型并解码 NF-κB 的参与
人类 HSC 生物学中的信号。
我们相信,拟议的研究将为以下问题提供重要见解:
涉及失调 NF-κB 信号的病理过程,并将有助于发育
针对人类血液疾病的更新、更成功的疗法
NF-κB 的组成型激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chozha Vendan Rathinam其他文献
Chozha Vendan Rathinam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chozha Vendan Rathinam', 18)}}的其他基金
NF-kB signaling in the control of Hematopoiesis
NF-kB 信号传导在造血控制中的作用
- 批准号:
10087951 - 财政年份:2017
- 资助金额:
$ 38.58万 - 项目类别:
GENETIC & MOLECULAR CONTROL OF E3 UBIQUITIN LIGASES IN STEM DIFFERENTIATION
基因
- 批准号:
8360045 - 财政年份:2011
- 资助金额:
$ 38.58万 - 项目类别:
相似海外基金
Computing analysis of leukemic stem cell dynamics in acute myelocytic leukemia
急性粒细胞白血病白血病干细胞动力学的计算分析
- 批准号:
19K08356 - 财政年份:2019
- 资助金额:
$ 38.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia
在急性髓细胞白血病中使用超靶向单克隆抗体产生免疫毒素
- 批准号:
23501309 - 财政年份:2011
- 资助金额:
$ 38.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556971 - 财政年份:1980
- 资助金额:
$ 38.58万 - 项目类别:
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556968 - 财政年份:1980
- 资助金额:
$ 38.58万 - 项目类别:
ERADICATION OF ACUTE MYELOCYTIC LEUKEMIA CELLS BY MAB THERAPY
通过 MAB 疗法根除急性粒细胞白血病细胞
- 批准号:
3889304 - 财政年份:
- 资助金额:
$ 38.58万 - 项目类别:














{{item.name}}会员




